Markers of inflammation and haemostasis: Associations with myocardial injury, adverse remodelling and future clinical events in patients with ST-elevation myocardial infarction
Year: 2018
Type: dissertation
Study design: Observational Study
Abstract: In this thesis we studied patients with acute ST- elevation myocardial infarction and their relation to different circulating biomarkers reflecting activation of the inflammatory and haemostatic system and a marker associated with ischemia/reperfusion injury and remodelling. We found that a novel inflammatory marker, soluble IL-6 receptor (sIL-6R) was associated with increased risk of future cardiovascular events including new myocardial infarction, readmission for heart failure, stroke or all-cause mortality. IL-6 and C-reactive protein as well as markers of hypercoagulability were associated with larger infarcts and reduced left ventricular function. CCN2, a marker of remodelling was not related with either infarct size, left ventricular function or increased risk of new adverse events, indicating that the soluble form of this protein does not play an important role in this setting. The main conclusion is that higher levels of sIL-6R in the sub-acute phase after a STEMI are associated with adverse prognosis. Inhibition of the IL-6 receptor may be a therapeutic approach.
Source: NVA (Nasjonalt vitenarkiv)
Author: Vibeke Ritschel
Institution: University of Oslo
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ST-elevation myocardial infarction, soluble IL-6 receptor, interleukin-6, C-reactive protein, hypercoagulability, inflammation, hemostasis, myocardial injury, infarct size, left ventricular function, connective tissue growth factor, cardiovascular events, prognosis, IL-6 receptor inhibition
Open Access status: green
OpenAlex ID: W2973008267
